Theseus Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -11.74 | -100% |
| P/S |
|
0 | 33.77 | -100% |
|
|
| P/BV |
|
0.9233 | 4.83 | -80.88% |
|
|
| P/FCF |
|
-2.56 | 61 | -104.2% |
|
|
| Ev/Ebitda |
|
-1.87 | -22.17 | -91.57% |
|
|
| Ev/S |
|
0 | 22.57 | -100% |
|
|
| Ev/FCF |
|
-2.03 | 68.76 | -102.96% |
|
|
| E/P |
|
-0.4447 | 0.0178 | -2602.01% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.97 | -100% | 0 | 0% |
| ROE |
|
-20.74 | 9.61 | -315.76% |
|
|
| ROA |
|
-19.89 | 0.3443 | -5877.96% |
|
|
| ROIC |
|
-13.74 | 7.63 | -279.98% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-25.62 | 15.45 | -265.82% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0739 | -3.68 | -97.99% | -0.0739 | +0.1019% |
| Nеt Debt/Ebitda |
|
1.67 | -3.44 | -148.72% |
|
|
| Debt/Ratio |
|
0.018 | 0.1986 | -90.94% |
|
|
| Debt/Equity |
|
9.62 | 1.66 | 478.42% |
|
|
| Debt/Net Income |
|
-0.0707 | 10.32 | -100.68% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -57.64 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
855.47 | -90.94 | -1040.7% | ||
| Growth impulse Net Income in 5 years |
|
708.74 | -97.8 | -824.68% | ||
| Growth impulse FCF in 5 years |
|
894.08 | -108.72 | -922.37% | ||
| Growth impulse EPS in 5 years |
|
193.33 | -142.05 | -236.1% |
IP Score
3.81/10
